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Edited by Lukas HuberAbstract Diﬀerent scaﬀold proteins play distinct roles in vari-
ous signaling pathways by recruiting diﬀerent downstream mole-
cules. Here, using MKK4/ and MKK4//7/ murine
embryonic ﬁbroblast cells, we examined diﬀerential employment
of MKK4 and MKK7 by scaﬀold proteins Axin, Dvl, and Ep-
stein–Barr virus latent membrane protein-1 (LMP-1) in mediat-
ing JNK activation. We present evidence that Axin depends
mainly on MKK7 for activation of JNK, while Dvl depends al-
most equally on MKK4 and MKK7 for JNK activation, In con-
trast, LMP-1-induced JNK activation is primarily dependent on
MKK4. Our results demonstrate that Axin, Dvl, and LMP-1 dif-
ferentially utilize MKK4 and MKK7 for JNK activation.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Mitogen-activated protein kinases (MAPK) are activated by
a cascade of upstream protein kinases. The immediate up-
stream kinases, know as MAP kinase kinases, are believed to
be dual-speciﬁc kinases, i.e. they are able to phosphorylate
both threonine and tyrosine on the conserved Thr-X-Tyr motif
located in the kinase activation loop of MAP kinases [1,2].
However, strong preference of MAP kinase kinases towards
either Thr or Tyr residue has been reported [3]. MKK4 and
MKK7 are the upstream kinases for the c-Jun N-terminal ki-
nase (JNK). Phosphoamino-acid analysis revealed that
MKK4 exhibits a strong preference for the tyrosine residue,
while MKK7 favors the threonine residue [4], all pointing to
a synergistic eﬀect of MKK4 and MKK7. Targeted gene-dis-
ruption studies in mice have also shown that deletion of both
MKK4 and MKK7 is suﬃcient to block JNK activation by
proinﬂammatory cytokines [5].Abbreviations: JNK, c-Jun N-terminal kinase; Dvl/Dsh, dishevelled;
MEKK, mitogen-activated protein kinase/extracellular signal-regu-
lated kinase kinase kinase; GFP, green ﬂuorescent protein; HA,
hemagglutinin; MEF, murine embryonic ﬁbroblast; LMP-1, Epstein–
Barr virus latent membrane protein-1
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doi:10.1016/j.febslet.2006.12.012While it is clear that stress- and cytokine-induced JNK acti-
vation requires both MKK4 and MKK7, it remains to be dem-
onstrated whether activation of JNK by intracellular factors or
viral proteins adopts the same mode. A variety of such intra-
cellular proteins have been shown to activate JNK when over-
expressed, which include Axin [6], Dvl [7], and LMP [8]. Axin
is a negative regulator of Wnt signaling in that its mutation re-
sults in axis duplication [9]. Without Wnt signaling, Axin
serves as a scaﬀold to assemble a multimeric protein complex
with adenomatous polyposis coli (APC), glycogen synthase ki-
nase-3b (GSK-3b) and b-catenin for down-regulation of b-
catenin [9,10]. As aforementioned, Axin also activates the
JNK cascade, by forming a complex with either MEKK1 or
MEKK4 [11]. Although the biological signiﬁcance of the
Axin-mediated JNK activation remains unclear, several lines
of evidence have clearly indicated that it is highly regulated
[11–13]. Dvl activates JNK signaling through its DEP domain
[14]. A defect in the ability to activate JNK that results from a
single amino acid substitution in the DEP domain of Dsh
(dsh1), leads to abnormality of epithelial planar polarity in
the dsh1 ﬂies. The mutant phenotype was rescued by Dsh trans-
genes expressing the DEP domain [15]. Of particular relevance
to the current study, another factor that activates JNK signal-
ing when overexpressed is LMP-1 [8].
To address if synergistic activation of JNK by MKK4 and
MKK7 also occurs in the activation cascade of JNK by scaf-
fold proteins, we used MEF (murine embryonic ﬁbroblast)
cells in which MKK4 and MKK7 have been genetically dis-
rupted. Coupled with siRNA approach in wild-type MEF or
MKK4 single knockout cells, we found that Axin eﬀectively
activated JNK in MKK4/ MEF cells. Knockdown of
MKK7 in wild-type MEF cells or in MKK4/ MEF cells
abolished JNK activation by Axin, indicating that Axin-in-
duced activation of JNK is mostly dependent on MKK7.
Knockdown of either MKK4 or MKK7 by respective siRNAs
diminished almost equally Dishevelled-induced JNK activa-
tion. In contrast, LMP-1 fails to activate JNK in MKK4/
MEF cells. Our ﬁndings thus demonstrate that diﬀerent activa-
tors of JNK may have distinct requirements for MKKs.2. Materials and methods
2.1. Cell lines and culture conditions
HEK 293 cell, HEK 293T cell, wild-type MEF cell, MKK4/MEF
cell and MKK4//7/-double knockout (MKK4/7 DKO) MEF cells
were maintained in DMEM supplemented with 10% FBS 100 IU ofblished by Elsevier B.V. All rights reserved.
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humidiﬁed 5% CO2 atmosphere.
2.2. Transient transfection
Transfection was performed in 60-mm dishes, using calcium phos-
phate transfection for HEK 293 and HEK 293T cells, and Lipofect-
amine 2000 for MEF cells according to the manufacturer’s
instructions (Invitrogen). The total amount of transfected DNA of
each plate was adjusted with the empty vector pCMV5 or pSUPER
where necessary.2.3. Construction of expression plasmids
Expression vectors for wild-type mouse HA-Axin, HA-Axin deletion
mutants D19 and M8, and FLAG-tagged JNK1 were generated as de-
scribed previously [11]. Wild-type full-length human MKK4 and
MKK7 were generated from fragments by polymerase chain reaction
using primers 5-catatggcggctccgagcccgagcggc-3 and 5-tctagatcaatcga
c atacatgggagagctgg-3 for MKK4, 5-catatggcggcgtcctccctggaacag-3
and 5-tctagactac c tgaagaagggcaggtgg-3 for MKK7. All PCR products
were veriﬁed by sequencing. MKK4 and MKK7 were fused in-frame
with hemagglutinin (HA) or Myc tag and cloned into the NdeI and
XbaI sites of the mammalian expression vector pCMV5. The expres-
sion plasmid of pcDNA3.0-LMP-1 was constructed as previously de-
scribed [8].2.4. Immunokinase assays and Western blotting
For immunokinase assay, 293T cells were transfected with FLAG-
JNK and other plasmids in diﬀerent combinations as indicated where
necessary. At 36 h posttransfection, cells were lysed in lysis buﬀer, fol-
lowed by immunoprecipitation with mouse monoclonal anti-FLAG
M2 beads (Sigma) for FLAG-JNK1. The precipitates containing
FLAG-JNK were subjected to kinase reaction in kinase buﬀer supple-
mented with l lg GST-c-Jun (amino acids 1–79; Stratagene) at 37 C
water bath for half an hour. The reaction samples were then boiled
and separated on 10% SDS–polyacrylamide gels and transferred to
polyvinylidene diﬂuoride membrane (Roche Diagnostics). After block-
ing with 5% skim milk in phosphate-buﬀered saline with 0.1% Tween
20 for 1 h, the membranes were probed with anti-HA (Santa Cruz Bio-
tech., Inc.) for Axin, anti-FLAG (M2, Sigma) for total FLAG-JNK
and anti-phospho-c-Jun (Ser 63) antibody for phosphor-c-Jun, individ-
ually. All the data shown for kinase assay were representative results
from at least three separate experiments.2.5. RNA interference
The pSUPER vector was used to construct siRNA expression vec-
tors that can speciﬁcally knockdown the expression of MKK4 and
MKK7. The following sequences were targeted: 5-attggacgaggagct-
tatg-3 for siMKK4, 5-agactgccttactaaagat-3 for siMKK7.2.6. Cell death assay
HEK 293, wild-typeMEF cells, MEFMKK4/ andMKK4//7/
DKO cells were placed in glass coverslips in 35-mm culture dishes.
Cells were transiently co-transfected with 1 lg pEGFP C3 (Clontech)
vector that expresses green ﬂuorescent protein (GFP), 2 lg HA-tagged
Axin, 1 lg of Myc-tagged MKK4 or MKK7 in diﬀerent combinations
by using Lipofectamine 2000 (Invitrogen). At 36 h post-transfection,
apoptosis assays were performed as previously described [16].3. Results
3.1. Knockdown of MKK4 and MKK7 diﬀerentially aﬀects
Axin-mediated JNK activation in 293T cells
To test whether MKK4 and MKK7 are diﬀerentially uti-
lized in Axin-mediated JNK activation, we ﬁrst generated
pSUPER constructs that express siRNAs against MKK4
and MKK7, respectively. Sequence blast revealed no se-
quence identity of the siRNA sequences to any other genes.We then co-expressed these pSUPER plasmids separately
with HA-tagged MKK4 and HA-tagged MKK7 in 293T cells,
and determined whether the siRNAs could speciﬁcally sup-
press expression of their targets by Western blotting analysis.
GFP was included in each transfection as an internal control.
Results showed that pSUPER-MKK4 and pSUPER-MKK7
could eﬀectively knockdown their respective targets with sim-
ilarly high eﬃciency (Fig. 1a and b). Then by using pSUPER-
MKK4 and pSUPER-MKK7, we investigated whether
knockdown of MKK4 and MKK7 could selectively abolish
Axin-induced JNK activation. HEK293T cells were co-trans-
fected with diﬀerent combinations of HA-tagged Axin,
FLAG-tagged JNK1, blank pSUPER, pSUPER-MKK4,
and pSUPER-MKK7 as indicated in Fig. 1c. Whereas pSU-
PER-MKK4 attenuated Axin-induced JNK activity approxi-
mately only by half, pSUPER-MKK7 almost abolished
JNK activation by Axin. As expected, Axin failed to activate
JNK when both pSUPER-MKK4 and pSUPER-MKK7 were
co-transfected. These results indicate that both MKK4 and
MKK7 are involved in the activation of JNK by Axin, and
that MKK7 contributes more than MKK4 to the activation
of JNK by Axin.
We recently showed that Axin utilizes MEKK1 or MEKK4
to activate JNK [11], although the mechanism by which
MEKK1 and MEKK4 compete against each other for Axin
binding is not clear. D19 and M8, two deletion mutants of
Axin, can interact with only one of the MEKKs, i.e. D19 inter-
acts with MEKK4 and M8 with MEKK1 [11]. It is therefore of
interest to determine which MEKK signals to MKK7 that
alone seems to be eﬀective in mediating Axin to activate
JNK. HA-Axin D19 and HA-Axin M8 were separately co-ex-
pressed with FLAG-JNK1 and siRNAs of MKK4 and MKK7
in 293T cells. As we can see in Fig. 1d and e, pSUPER-MKK4
could reduce D19- or M8-induced JNK activation approxi-
mately by half, displaying the same pattern that seen with
pSUPER MKK4 and wild type Axin. pSUPER-MKK7 dras-
tically attenuated JNK activation, and co-existence of siRNAs
against both MKK4 and MKK7 completely abolished JNK
activation. These results indicate that both MKK4 and
MKK7 are required for maximal activation of JNK by Axin,
and that both MAP3Ks depend more on MKK7 to mediate
Axin activation of JNK.3.2. MKK7 alone leads to signiﬁcant activation of JNK by Axin
in MEF cells
To further conﬁrm our observations, we conducted similar
experiments in mouse embryonic ﬁbroblast (MEF) cells, which
include wild-type MEF, MKK4/and MKK4//7/ MEF
cell lines. FLAG-JNK1 was co-expressed with HA-Axin, Axin
D19 or Axin M8 separately in the diﬀerent MEF cells. Similar
to what was seen in 293T cells, strong activation of JNK by
each of Axin wild-type and Axin deletion mutants D19 and
M8 was seen in the wild-type MEF cells (Fig. 2a), moderate
activation was detected in MEF MKK4/ cells (Fig. 2b) with
no activation of JNK by any Axin constructs in MKK4//7/
cells (Fig. 2c). We then co-transfected HA-Axin, FLAG-JNK1
and pSUPER-MKK7 in MEF MKK4/ cells and performed
JNK assay. Overexpression of pSUPER-MKK7 dramatically
attenuated Axin-induced JNK activation (Fig. 2d). These re-
sults demonstrate again that MKK7 contributes more than
MKK4 in Axin-mediated JNK activation.
Fig. 1. Axin mainly depends on MKK4 and MKK7 for activation of JNK in 293T cell. Panel a: HEK 293T cells were co-transfected with 1 lg of
HA-MKK4 or HA-MKK7 together with 4 lg of pSUPER-MKK4 and 1 lg of pEGFP-C3. MKK4, MKK7 and GFP were detected with anti-HA
and anti-GFP, respectively. Panel b: 1 lg of HA-MKK4 or HA-MKK7 together with 4 lg of pSUPER-MKK7 and 1 lg of pEGFP-C3 was co-
expressed in 293 T cell. Western blotting was performed as described above. Panel c. HEK 293T cells was co-transfected with diﬀerent combinations
of HA-Axin, FLAG-JNK1, pSUPER-MKK4 and pSUPER-MKK7. Immunokinase assays were performed as described in Section 2. Panel d: 293T
cells were transfected with diﬀerent combinations of HA-Axin D19, FLAG-JNK1, pSUPER-MKK4 and pSUPER-MKK7, followed by kinase
assay. Panel e: In 293T cells, HA-Axin M8 and FLAG-JNK1 were transfected with pSUPER-MKK4 alone, pSUPER-MKK7 alone or both of them.
After 36 h of transfection, immunokinase assays were performed.
198 H. Zou et al. / FEBS Letters 581 (2007) 196–2023.3. Axin, dishevelled, and latent membrane protein-1 (LMP-1)
display diﬀerential dependence on MKK4 and MKK7 for
JNK activation
Like Axin, Dishevelled and LMP-1 each can trigger JNK
activation when overexpressed, despite the fact that they utilize
diﬀerent mechanisms [8,14]. Whereas Axin seems to form a
complex with either MEKK1 or MEKK4 to activate MKKs,
Dishevelled activates JNK by linking to small G protein Rac
[17]. LMP-1 activates JNK through sequential activation of
TRAF6, TAK/TAB1, and MKK4/7 [8]. Sorbitol, which im-
poses an osmotic stress on cells, can also activate JNK through
Ras, and was used for comparison [18].
Our current ﬁnding that MKK7 alone could mediate signif-
icant activation of JNK by Axin prompted us to ask if other
scaﬀold proteins such as Dishevelled and LMP-1 exhibit a sim-
ilar dependence on MKKs. In 293T cells, Dvl and JNK were
co-transfected with pSUPER-MKK7 and pSUPER-MKK4
in diﬀerent combinations, followed by immuno-kinase assay
for JNK activity. As shown in Fig. 3a, co-expression of siRNA
against MKK4 or MKK7 alone signiﬁcantly reduced JNK
activation by Dvl. When both siRNAs were present, Dvl failed
to activate JNK. In MEF cells, Dvl robustly activated JNK inthe wide-type cells, and moderately activated JNK inMKK4/
cells (Fig. 3b), but not in MKK4//7/ cells (Fig. 3c). These
results imply that Dvl depends on MKK4 and MKK7 to a
similar extent for JNK activation. LMP-1 and sorbitol acti-
vated JNK at similar levels to those by Axin in wild-type
MEF cells (Fig. 4a). However, in MEF MKK4/cells, JNK
activation by either LMP-1 or sorbitol was almost completely
abolished (Fig. 4b), which is in great contrast to what was seen
with Axin or Dvl in the same cells. In MEF MKK4//7/
cells, neither LMP nor sorbitol could activate JNK (Fig. 4c).
3.4. MKK7 plays a major role in Axin-mediated cell death
We and others have previously shown that overexpression of
Axin leads to cell death, which at least in part depends on its
JNK-activating property [19,20]. Here, we made use of
MKK4/7-knockout cell lines and siRNA constructs against
MKK4/7 to further test the importance of MKK4/7 in Axin-
mediated cell death. We ﬁrst examined HEK 293 cells transfec-
ted with Axin and siRNAs against MKK4 and MKK7, along
with EGFP expression plasmid. At 36 h posttransfection, cells
were stained with Hoechst 33342 and observed for the blue-
stained nuclei under a ﬂuorescence microscope. As shown in
Fig. 2. Contribution of MKK4 and MKK7 to the activation of JNK by Axin in MEF cells Panel a: 4 lg of Axin, Axin D19, or M8, together with
4 lg of FLAG-JNK1 were transfected into wild-type MEF cells. After 36 h of transfection, immunokinase assays and Western blotting were
performed as described previously. Panel b: MEF MKK4/ cells were co-transfected with Axin, Axin D19, or M8, together with FLAG-JNK1.
Immunokinase assays and Western blotting were performed accordingly. Panel c: Axin, Axin D19 (D MEKK1) or M8 (D MEKK4) were
cotransfected with FLAG-JNK into MEF MKK4//7/ cells, followed by immunokinase assays. Panel d: MEF MKK4/cells were transfected
with HA-Axin, FLAG-JNK1 and pSUPER-MKK7.
Fig. 3. Eﬀect of MKK4 and MKK7 on activation of JNK by Dishevelled Panel a: Myc-Dishevelled, FLAG-JNK1, pSUPER-MKK4 and pSUPER-
MKK7 were co-transfected into 293T cells in diﬀerent combinations, followed by kinase assay and Western blotting. Panel b: Myc-Dishevelled and
FLAG-JNK1 were co-expressed in MEF wild-type cells and MKK4/ cells. After 36 h of transfection, kinase assay and western blotting were
performed. Panel c: Myc-Dishevelled and FLAG-JNK1 were co-transfected into MEF wild-type cells and MKK4//7/ cells, followed by
immunokinase assays and Western blotting.
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Fig. 4. Comparison of Axin, Sorbitol and LMP-1 for MKK4 and MKK7 requirement in JNK activation. Panel a: HA-Axin or LMP-1 was
transfected with FLAG-JNK1 into MEF wild-type cells. After 36 h of transfection, one plate of cells transfected with empty-vector was treated with
0.4 mol/L sorbitol for 30 min. Then all plates of cells were subjected to kinase assays and Western blotting. Panel b: MEF MKK4/ cells were co-
transfected with JNK1 and HA-Axin or LMP-1. Cells were treated with 0.4 mol/L sorbitol for 30 min before harvest, followed by immunokinase
assays. Panel c: In MEF MKK4//7/ cells, HA-Axin or LMP-1 were co-transfected with JNK1. Cells were treated with sorbitol, and
immunokinase assays and Western blotting were carried out.
Fig. 5. Contribution of MKK4 and MKK7 to Axin-induced cell death by activation of JNK. Panel a: 293 cells were transiently transfected with HA-
Axin, pEGFP and pSUPER-MKK4 or pSUPER-MKK7 in diﬀerent combinations. Cell death was quantiﬁed 36 h after transfection by Hoechst
33324 staining, and results were means ± S.D. of ﬁve independent experiments. Panel b: MEF wild-type cells were cotransfected with HA-Axin,
pEGFP, pSUPER-MKK4 and pSUPER-MKK7 in diﬀerent combinations. After 36 h of transfection, cell death was quantiﬁed. Panel c: HA-Axin
and pEGFP were co-transfected with pSUPER-MKK7 into MEF MKK4/ cells. Cell death was determined as before.
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apoptosis as judged by nuclear condensation and fragmenta-
tion. In contrast, death percentage of cells co-transfected with
pSUPER-MKK4, pSUPER-MKK7, or both of them, was32%, 26%, and 18%, respectively, indicating that both
MKK4 and MKK7 are required for maximal induction of cell
death by Axin, and that MKK7 plays a major role. Similar
results were observed in wild-type MEF cells (Fig. 5b). To
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MKK7 was co-transfected with Axin into MEF MKK4/
cells. As shown in Fig. 5c, Axin alone still induced a high death
rate of 32%, when pSUPER-MKK7 was introduced, cell death
rate decreased to 21%, further indicating that MKK7 plays
a key role in Axin-induced cell death through activation of
JNK.4. Discussion
It is well known that a MAP kinase cascade consists of three
key components, namely MAP3K, MAPKK, and MAP kinase
[21]. MEKK1 andMEKK4 that act asMAP3K are competitive
in binding to Axin, which raises a possibility that they may be
involved in diﬀerent signaling pathways [11]. Our data pre-
sented in this report indicate that there is no selectivity of
MKK4 and MKK7 in MEKK1- or MEKK4-mediated JNK
activation by Axin (Fig. 1d and e). Surprisingly, we observed
signiﬁcant diﬀerences in the usage of MKK4 or MKK7 be-
tween JNK activation mediated by Axin and by other JNK-
activating scaﬀold proteins. MKK4 and MKK7 are the two
direct upstream kinases of JNKs [22]. To date, a number of
studies have demonstrated their essential role in JNK activa-
tion triggered by a variety of stimuli and stresses. The contribu-
tion of MKK4 and MKK7 in JNK activation in a given cell
type can be inﬂuenced by the relative protein levels of these
MKKs and selective upstream activators. Their expression lev-
els should be cell type-speciﬁc, which may provide an explana-
tion as to why selective activation in a given cell can be inducer-
speciﬁc. Currently, there is no eﬀective method to assess
whether MKK4 is expressed higher than MKK7 or vice versa,
because it is diﬃcult to compare the titers of their antibodies.
We have compared JNK activation by three diﬀerent scaﬀold
proteins in the same experimental system to evaluate speciﬁc
contribution of MKK4 and MKK7 in JNK activation by indi-
vidual scaﬀold proteins. We show that Axin-mediated JNK
activation depends mainly on MKK7, Dvl-induced JNK acti-
vation almost equally depends on MKK4 and MKK7, while
in contrast, LMP-mediated JNK activation is primarily depen-
dent on MKK4. Existing data show that the presence of both
MKK4 and MKK7 is required for maximal activation of
JNK in all cases examined. Diﬀerent contributions of these
two MKKs to proinﬂammatory cytokines- and environmental
stresses-induced JNK activation have also been reported [5]. In
this study, we found that both MKK4 and MKK7 are also re-
quired for maximal activation of JNK by scaﬀold proteins, and
revealed perplexing patterns of distinct requirements of MKK4
and MKK7 by diﬀerent scaﬀold proteins in mediating JNK
activation. It is therefore clear that there is a partial redundancy
of MKK4 or MKK7 in regulating JNK activation. In addition,
these ﬁndings also suggest a distinct functional speciﬁcity of
MKK4 and MKK7, although the exact mechanism for the dis-
tinct selections of MKKs in diﬀerent JNK activations remains
to be elucidated. In sum, we further suggest a provocative pos-
sibility that diﬀerent scaﬀold proteins may crosstalk to other
cascades that can render lesser dependence on MKKs.
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